Vectra 3D 3 Pipettes Dogs 4-10 Kg Green

NAME:
VECTRA 3D

PHARMACOTHERAPEUTIC CATEGORY:
Ectoparassicides for topical use.

ACTIVE INGREDIENTS:
Dinotefuran, pyriproxifene, permethrin.

EXCIPIENTS:
N-octyl-2-pyrrolidone, N-methylpyrrolidone.

INDICATIONS:
Fleas: treatment and prevention of infestation by fleas (Ctenocephal ides felis and Ctenocephalides canis).
The treatment prevents flea infestation for one month.
It also prevents the multiplication of fleas for two months after application by inhibiting the opening of the eggs (acts of ovicidal life) and inhibiting the appearance of adults from eggs laid by adult fowls (larvicidal activity).
The veterinary medicinal product can be used as part of a treatment strategy for allergy dermatitis from fleas (FAD).
Ticks: the veterinary medicinal product has persistent acaricidal efficacy and repellent action against z ecche infestations (Rhipicephalus sanguineus and Ixodes ricinu s for one month, and Dermac entor reticulatus for up to three weeks).
If ticks are present when the veterinary medicinal product is applied, they may not all be killed within the first 48 hours but may die within a set timana.
To remove ticks it is recommended to use a special device for the removal of ticks.
Sand flies, mosquitoes and mosc he: the treatment provides persistent repellent activity (anti-fee ding ).
Prevents bites from sand flies (Phlebotomus perniciosus), zan zare (Culex pipiens, Aedes aegypti) and flies (Stomoxys calcitrans) for one month after application.
The treatment also provides persistent insecticidal activity for one month against mosquitoes (Aedes aegypti) and mos that (Stomoxys calcitrans).

CONTRAINDICATIONS / EFF.SECONDAR:
Do not use in case of hypersensitivity to one or more active ingredients or to one of the excipients.
Do not use on cats.
Due to their particular physiolog Inability to metabolise permethrin, this veterinary medicine should not be used on cats.
If applied to a cat, or ingested by a cat that has actively rubbed itself on a recently treated dog, this veterinary medicinal product may 'to determine serious harmful reactions.

USE / ROUTE OF ADMINISTRATION:
Topical.

DOSAGE:
The minimum recommended dose is 6.4 mg dinotefuran / kg body weight, 0.6 mg pyriproxyphene / kg body weight and 46.6 mg permethrin / kg body weight, equivalent to 0.12 ml of the veterinary medicinal product per kg body weight.
Use the appropriate packaging according to the body weight of the animal.
Pay attention to apply the veterinary medicinal product only to intact skin.
Avoid superficial application to the dog's coat.
Treatment scheme: following a single application, the veterinary medicinal product will prevent infestation for one month.
Treatment can be and repeated once a month.

STORAGE:
This veterinary medicinal product does not require any special storage conditions.

WARNINGS:
Must be treated all dogs in the house.
House cats should only be treated with a veterinary medicinal product authorized for use in that species.
Fleas can infest the basket, the kennel and the usual areas of dog rest such as carpets and sofas and armchairs.
In case of massive flea infestation and at the beginning of control measures, these areas should be treated with an appropriate insecticide and then vacuumed regularly.
This veterinary medicine in cats can induce convulsions which can and can be fatal, due to the particular physiology of this species which is unable to metabolize some compounds, including permeth ina.
In case of accidental exposure, if undesirable effects appear erati, wash the cat with shampoo or soap.
To prevent cats from accidentally coming into contact with this veterinary medicinal product, keep cats away from treated dogs until the application site is dry.
It is important to ensure that cats do not rub over the application site of a dog that has been treated with this veterinary medicinal product.
The safety of this veterinary medicinal product has not been proven in older dogs. less than 7 weeks or weighing less than 1.5 kg.
Care should be taken to avoid contact between this veterinary medicinal product and the dog's eyes.
No attack of a single tick after treatment.
For this reason the transmission of infectious diseases cannot be completely ruled out if conditions are favorable.
Veterinary medicine remains effective when treated animals are imme rmed. in water (eg.
when they swim, they bathe).
Repeated immersion in water weekly for a month and starting from 48 hours after treatment, as well as shampooing 2 weeks after treatment has no effect on the effectiveness of this product.
However, the duration of efficacy may be reduced in case of frequent shampooing, or soaking within 48 hours after treatment.
Special precautions for those administering the product to animals: do not eat, drink or smoke when handling the veterinary medicinal product.
Wash hands thoroughly and immediately after use.
This veterinary medicinal product causes irritation of the eyes and skin.
Avoid contact with skin.
In In case of accidental spillage on the skin, wash immediately with soap and water.
If the veterinary medicinal product comes into contact with the eyes, they should be rinsed thoroughly with water.
If the eye or skin irritation persists, or if veterinary medicine is used accidentally ingested, seek medical advice immediately and show the package leaflet or the label to the physician.
People with known hypersensitivity to any of the components should avoid contact with the veterinary medicinal product.
Children should not treated dogs should be touched for at least four hours after administration of the veterinary medicinal product.
It is therefore advisable to treat dogs in the evening, or before taking them for a walk.
On the day of treatment, you should not allow treated dogs to sleep with their owners, especially children.
Used applicators must be disposed of immediately and must not be left in sight and within reach of children.
Wait for the application site to be dry before allowing treated dogs to come into contact with fabrics or objects.
Other precautions: treated dogs should not be allowed to enter waterways for 48 hours after treatment to avoid reactions adverse to aquatic organisms.
Overdose: Except for erythema and changes in coat appearance, no adverse reactions were observed in healthy puppies aged 7 weeks, treated topically 7 times at intervals 2 weeks and up to 5 times the maximum recommended dosage.
In case of accidental ingestion at the recommended dosage or maximum, vomiting, salivation and dia rrea may appear which should however disappear without treatment.
Incompatibles ': do not mix with other veterinary medicinal products and do not apply them together with other veterinary medicinal products simultaneously and in the same site.

WITHDRAWAL TIME:
Not relevant.

TARGET SPECIES:
Dogs.

INTERACTIONS:
None known.

UNDESIRABLE EFFECTS:
Very rarely (less 1 in 10,000 animals, including isolated reports) erythema, pruritus or other signs of m transient being at the application site which usually disappeared spontaneously within 24 hours after administration of the product.
Gastrointestinal symptoms such as vomiting or diarrhea have also been reported very rarely.
Effects and aesthetics have been reported very rarely. transient (greasy, matted appearance of the hair and accumulations) at the application site, however these effects are usually no longer visible after 48 hours.

PREGNANCY AND NURSING:
The safety of the medicine veterinary medicinal product in bitches has not been established during pregnancy and lactation.
The use of the veterinary medicinal product in pregnant and lactating bitches or in dogs intended for breeding should be based on risk / risk assessment. be neficio.
Laboratory studies, with each of the components, dinotefuran, pyriproxyphene or permethrin, in rats and rabbits did not show maternotoxic, teratogenic or fetotoxic effects.
It was p found that dinotefuran crosses the blood-mammary barrier and is excreted in milk.
N-methylpyrrolidone, an excipient of the veterinary drug or, has shown teratogenicity in laboratory animals.

& nbsp;